Is a complete RGEN research report available?

No complete published report is available for Repligen Corporation (RGEN) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

RGEN Stock Analysis, Forecast & Valuation

Market cap	7.4B
Revenue (ttm)	763.3M
Net income (ttm)	51.4M
EPS (ttm)	$0.91
Shares out	56.4M
P/E (trailing)	145.0x
P/E (forward)	62.7x
Volume	1,359,901
Beta	1.06

Price target	$178	+34.9%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All RGEN indicators

Market & fundamental data

Available fields

270

Groups with data

Currency

USD

Showing 270 of 270 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000730272
Company name	Repligen Corporation
Country	United States
Country code	US
Cusip	759916109
Employees	2,000
Employees Change	222%
Employees Change Percent	12.49
Enterprise value	$7.4B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
Industry PE	64.87
Industry PE Fwd	20.65
Isin	US7599161095
Last refreshed	2026-07-27
Market cap	$7.4B
Market cap category	Mid-Cap
Price	$132
Price currency	USD
Rev Per Employee	381,669.5x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.69
Sic	2836
Symbol	RGEN
Website	https://www.repligen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.69%
EV Earnings	143.01x
EV Sales Forward	8.68x
EV/EBIT	113.91x
EV/EBITDA	50.93x
EV/FCF	69.32x
EV/Sales	9.63x
FCF yield	1.42%
Forward P/E	62.73x
P/B ratio	3.53x
P/E ratio	145.04x
P/S ratio	9.76x
PE Ratio10 Y	265.09x
PE Ratio3 Y	782.03x
PE Ratio5 Y	432.2x
PEG ratio	3.11x
PS Forward	8.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.45%
EBITDA Margin	18.91%
FCF margin	13.89%
Gross margin	53.14%
Gross Profit	$405.6M
Gross Profit Growth	21.92%
Gross Profit Growth Q	18.51%
Gross Profit Growth3 Y	-0.77%
Gross Profit Growth5 Y	10.08%
Net Income	$51.4M
Net Income Growth Q	42.93%
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Net Income Growth3 Y	-30.68%
Net Income Growth5 Y	-8.37%
Pretax Margin	7.36%
Profit Margin	6.73%
Profit Per Employee	$25,699
Profitable Quarters	$5
Profitable Years	1
ROA	1.18
Roa5y	2.61
ROCE	2.3
ROE	2.51
Roe5y	4.18
ROIC	2.47
Roic5y	5.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	16.98%
Cagr15y	26.91%
Cagr1y	12.67%
Cagr20y	22.44%
Cagr3y	-9.04%
Cagr5y	-8.87%
EPS Growth Q	47.87
EPS Growth Quarters	5
EPS Growth Years	1
EPS Growth3 Y	-30.48
EPS Growth5 Y	-8.97
FCF Growth	-15.03%
FCF Growth Q	106.13%
FCF Growth3 Y	4.11%
FCF Growth5 Y	23.81%
OCF Growth	-10.29%
OCF Growth Q	88.57%
OCF Growth10 Y	25.44%
OCF Growth3 Y	-6.54%
OCF Growth5 Y	15.95%
Revenue Growth	17.36x
Revenue Growth Q	14.83x
Revenue Growth Quarters	7x
Revenue Growth Years	2x
Revenue Growth3 Y	0.12x
Revenue Growth5 Y	12.01x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.26
Assets	$2.9B
Cash	$784.5M
Current Assets	$1.2B
Current Liabilities	$126.2M
Debt	$687.6M
Debt EBITDA	$4.76
Debt Equity	$0.33
Debt FCF	$6.48
Equity	$2.1B
Interest Coverage	2.75
Liabilities	$825.3M
Long Term Assets	$1.8B
Long Term Liabilities	$699.1M
Net Cash	$96.9M
Net Cash By Market Cap	$1.3
Net Cash Growth	616.21%
Net Debt EBITDA	$-0.67
Net Debt Equity	$-0.05
Net Debt FCF	$-0.91
Tangible Book Value	$630.4M
Tangible Book Value Per Share	$11.18
WACC	9.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.2
Inventory Turnover	2.15
Net Working Capital	$271.7M
Quick ratio	7.45
Working Capital	$1B
Working Capital Turnover	$0.8

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.01%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	379.86%
1Y total return	12.66%
200-day SMA	139.9
3Y total return	-24.74%
50-day SMA	130.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-37.14%
All Time High	327.3
All Time High Change	-59.68%
All Time High Date	2021-09-23
All Time Low	0.5
All Time Low Change	26,292%
All Time Low Date	1996-07-15
ATR	7.3
Beta	1.06
Beta1y	1.19
Beta2y	0.98
Ch YTD	-19.47
High	138.1
High52	175.8
High52 Date	2026-01-06
High52ch	-24.92%
Low	131.8
Low52	101
Low52 Date	2026-05-14
Low52ch	30.67%
Ma50ch	1.39%
Premarket Change Percent	0.05
Premarket Price	$138
Price vs 200-day SMA	-5.71%
RSI	42.06
RSI Monthly	46.94
RSI Weekly	49.73
Sharpe ratio	0.4x
Sortino ratio	0.75
Total Return	-1.01%
Tr YTD	-19.47
Tr15y	3,466.49%
Tr1m	4.42%
Tr1w	-10.38%
Tr3m	15.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	22
Analyst Count Top	8
Analyst Price Target Top	$184
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$0.45
Earnings EPS Estimate Growth	21.62
Earnings Revenue Estimate	201,211,736x
Earnings Revenue Estimate Growth	10.56x
Operating Income	$54.4M
Operating Income Growth	32.69
Operating Income Growth Q	102.2
Operating Income Growth3 Y	-29.21
Operating Income Growth5 Y	-11.6
Operating margin	7.13
Price target	$178
Price Target Change	$34.93
Price Target Change Top	$39.11

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	53,390,889%
Float Percent	94.6%
Shares Insiders	0.47%
Shares Institutions	118.84%
Shares Out	56,435,621
Shares Qo Q	0.01%
Shares Yo Y	1.01%
Short Float	11.33%
Short Ratio	5.46
Short Shares	10.72

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$72.4M
Average Volume	1,190,449.7x
Bv Per Share	37.33
CAPEX	$-24.7M
Ch10y	379.9
Ch15y	3,466.5
Ch1m	4.42
Ch1w	-10.38
Ch1y	12.66
Ch20y	5,637.4
Ch3m	15.69
Ch3y	-24.74
Ch5y	-37.14
Ch6m	-18.71
Change	-4.1%
Change From Open	-4.47
Close	137.6
Days Gap	0.39
Depreciation Amortization	79,803,000
Dollar Volume	179,452,536
Earnings Date	2026-07-28
Earnings Time	bmo
EBIT	$64.5M
EBITDA	$144.3M
EPS	$0.91
F Score	7
FCF	$106M
FCF EV Yield	1.44x
FCF Per Share	$1.88
Financing CF	-15,718,000
Fiscal Year End	December
Founded	1,981
Goodwill	1,106,874,000
Graham Number	27.64476
Graham Upside	-79.05
Income Tax	$4.8M
Investing CF	-228,354,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Lynch Fair Value	$4.55
Lynch Upside	-96.55
Ma150	134.6
Ma150ch	-1.97%
Ma20	141.8
Ma20ch	-6.96%
Net CF	-112,589,000
Next Earnings Date	2026-07-28
Open	138.1
Optionable	Yes
P FCF Ratio	70.23
P OCF Ratio	56.98
Position In Range	2.22
Ppne	287,105,000
Pre Close	137.6
Price Date	2026-07-24
Price EBITDA	$51.6
Ptbv Ratio	11.81
Relative Volume	1.14x
Revenue	763,339,000x
SBC By Revenue	4.41x
Share Based Comp	33,654,000
Tax By Revenue	0.63x
Tax Rate	8.57%
Tr20y	5,637.39%
Tr6m	-18.71%
Us State	Massachusetts
Volume	1,359,901
Z Score	6.54

Repligen Corporation (RGEN)

Coverage state: Market snapshot only — no published research

Generate the first RGEN analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · RGEN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RGEN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on RGEN

Frequently asked questions